Indeed Snapshot

Track BioMarin Pharmaceutical reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 29th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 68.0 59.0 71.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 42.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 29th, 2022 11:35AM Aug 29th, 2022 11:35AM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 28th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 68.0 59.0 71.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 42.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 28th, 2022 04:34AM Aug 28th, 2022 04:34AM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 27th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 68.0 59.0 71.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 42.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 27th, 2022 03:54AM Aug 27th, 2022 03:54AM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 25th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 68.0 59.0 71.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 42.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 25th, 2022 08:33AM Aug 25th, 2022 08:33AM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 23rd, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 68.0 59.0 71.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 42.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 23rd, 2022 10:27AM Aug 23rd, 2022 10:27AM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 21st, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 69.0 59.0 71.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 42.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 21st, 2022 12:10PM Aug 21st, 2022 12:10PM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 20th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 69.0 59.0 71.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 42.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 20th, 2022 01:47PM Aug 20th, 2022 01:47PM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 19th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 69.0 59.0 72.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 41.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 19th, 2022 12:10PM Aug 19th, 2022 12:10PM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 18th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 69.0 59.0 72.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 41.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 18th, 2022 03:53AM Aug 18th, 2022 03:53AM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology
nasdaq:bmrn https://www.indeed.com/cmp/biomarin Aug 17th, 2022 12:00AM Open BioMarin Pharmaceutical Inc. Pharmaceutical & Biotechnology BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients with serious and life-threatening rare genetic diseases. We remain steadfast to our mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, and have few, if any, treatment options. 3.90 69.0 59.0 72.0 63.0 59.0 59.0 57.0 67.0 57.0 61.0 59.0 64.0 68.0 41.0 146.00 146.00 3.70 4.10 3.50 3.40 3.70 19.00 About two weeks 23.00 DIFFICULT 22.00 FAVORABLE Aug 17th, 2022 09:32AM Aug 17th, 2022 09:32AM BioMarin Pharmaceutical Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.